Editorial introductions

Abstract

Current Opinion in Cardiology was launched in 1985. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of cardiology is divided into 14 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue. SECTION EDITORS Neal S. KleimanNeal S. KleimanDr Neal S. Kleiman is the Medical Director of the Cardiac Catheterization Laboratories at the Methodist DeBakey Heart & Vascular Center at The Methodist Hospital, Houston, USA, and a Professor at Weill Cornell Medical College, New York, USA. He has special interests in angioplasty, stenting, coronary artery diseases and interventional cardiology. His research lies in the relationship between angioplasty, stenting and clotting. His laboratory, recognized nationally as a select site for platelet research, examines the effects of antiplatelet therapy, the use of medications to prevent platelets from clumping and blood from clotting in patients with coronary artery disease who undergo angioplasty procedures. Kleiman has been the principal investigator and/or collaborating investigator in more than 100 studies and multi-center trials related to arterial thrombosis, the formation of blood clots in the arteries, clotting and angioplasty, which have altered the management of patients with chest pain undergoing catheterization. After receiving his medical degree from Columbia University in New York, USA, Kleiman completed an internship and residency in internal medicine at Baylor College of Medicine, USA, as well as a fellowship in cardiology. Kleiman has published over 150 manuscripts, book chapters and abstracts. His work has appeared in such publications as the Journal of the American College of Cardiology, Annals of Thoracic Surgery, Journal of Cardiovascular Pharmacology, Circulation, The American College of Cardiology and The European Heart Journal. He is on the editorial board of The Journal of Interventional Cardiology, Circulation, The American Heart Journal and The Journal of Thrombosis and Thrombolysis. Kleiman is a member of numerous professional organizations including The American Heart Association Council on Clinical Cardiology and Council on Thrombosis, and he is a fellow of The American College of Cardiology and the Society for Coronary Angiography and Interventions. Stefano F. RimoldiStefano F. RimoldiStefano F. Rimoldi received the MD degree from the University of Bern, Switzerland, in 2001 and the Swiss certificate (FMH) in internal medicine in 2007 and in cardiology in 2012. From 2007–2009, he was a fellow in the Research Division of Arterial Hypertension and High Altitude Medicine at the University of Bern. From 2010–2012, he has been working as a postdoctoral fellow with Prof. U. Scherrer at the Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland. Since 2014, he has been the Head of the Hypertension Division of the Department of Cardiology at the Bern University Hospital, Bern. (Head: Prof. B. Meier and Prof. S. Windecker). He received several research grants from the Swiss National Research Foundation, the Swiss Society of Hypertension and the Swiss Society of Cardiology. Franz H. MesserliFranz H. MesserliFranz H. Messerli, MD, is an expert in hypertensive cardio-vascular disease and preventive cardiology. He presently is Professor of Medicine at Mount Sinai Health Medical Center, USA, Icahn School of Medicine in the Division of Cardiology, USA, and Visiting Professor in the Department of Cardiology, Bern University Hospital, Bern, Switzerland. After earning his medical degree from the University of Bern Medical School in Switzerland, Dr. Messerli completed his post-graduate training in internal medicine and cardiology at the University of Bern. This was followed by a research fellowship at the Clinical Research Institute and the Hotel Dieu Hospital in Montreal, Canada. Before coming to New York, Dr. Messerli was for many years Director of Clinical Research at the Ochsner Clinical Foundation, USA, and Clinical Professor of Medicine at Tulane University School of Medicine in New Orleans, USA. He served on the Cardiorenal Advisory Committee of the Food and Drug Administration (FDA) and is or has been a member of the editorial board of Circulation, Journal of the American College of Cardiology, European Heart Journal, Hypertension, American Journal of Cardiology, Journal of Hypertension, etc. On his CV there are more than 800 publications and he has been first author on several papers in the New England Journal of Medicine, Lancet, Jama, Annals of Internal Medicine etc. As principal investigator he participated in numerous clinical trials. For his scientific achievements Dr. Messerli has received several awards among them recently a Honoris Causa Doctorate from the Jagiellonian University in Krakow, Poland, and most recently the Alberto Zanchetti Life Achievement Award of the European Society of Hypertension. Dimitri P. MikhailidisDimitri P. MikhailidisDimitri P. Mikhailidis is Academic Head and Reader and Honorary Consultant in the Department of Clinical Biochemistry at the Royal Free Hospital campus, University College London Medical School, University College London (UCL), UK. His clinical interest is vascular disease prevention, and his research interests are dyslipidaemias and thrombosis. He is a former Wellcome Trust fellow. Dr Mikhailidis has over 16,400 citations listed in the ISI index. He is editor in chief of several journals including Current Medical Research and Opinion, Current Vascular Pharmacology and Expert Opinion on Pharmacotherapy. He has participated in guideline committees. He is a former member of the nucleus group for peripheral arterial disease of the European Society of Cardiology. Anthony S. WierzbickiAnthony S. WierzbickiProfessor Anthony S. Wierzbicki is consultant in metabolic medicine/chemical pathology at Guy's & St. Thomas’ Hospitals, UK, and honorary Professor in Lipids & Cardiometabolic Disease at King's College, London, UK. His research interests are in the relationship of lipids to atherosclerosis and the role of lipids in peroxisomal diseases. He has been awarded fellowships of the American Heart Association and of the National Academy of Clinical Biochemistry (USA) for his contributions to atherosclerosis and lipid biology which include 300 publications, 19 book chapters and 1 book. He was a trustee of HEART-UK and was chairman of this charity's medical and scientific committee. For NICE he served on the technology and diagnostic appraisal committees and the Familial Hypercholesterolaemia guideline development group (CG71) and as chair of the Lipid Modification Guideline Development Group.